PEAK6 Group’s VivoSim Labs VIVS Stock Holding History

PEAK6 Group’s Portfolio VIVS Stock Details VIVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-104	Closed	-$62K	–	5142
2015 Q4	$62K	Hold	104	–	–	﹤0.01%	4187
2015 Q3	$67K	Sell	104 -238	-70%	-$181K	﹤0.01%	4547
2015 Q2	$310K	Buy	+342	New	+$383K	﹤0.01%	3287

Other funds holding VIVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

PEAK6 Group's VIVS Position: Q1 2016 in Review

PEAK6 Group sold out of VivoSim Labs (VIVS) in Q1 2016, closing a stake of 103 shares — an estimated $61K sold.

PEAK6 Group first reported a position in VIVS in Q2 2015 and held it in 3 quarters. The position peaked at $214K in Q2 2015. 109 funds tracked by Wall St. Rank hold VIVS as of Q1 2016.

PEAK6 Group reported no remaining VivoSim Labs position as of Q1 2016 after selling out during the quarter.
PEAK6 Group sold 103 VivoSim Labs shares in Q1 2016, an estimated $61K.
PEAK6 Group first reported a position in VivoSim Labs in Q2 2015 and held it in 3 quarters.
PEAK6 Group's VivoSim Labs position peaked at $214K in Q2 2015.
109 funds tracked by Wall St. Rank held VivoSim Labs as of Q1 2016.

Based on PEAK6 Group's 13F filing for Q1 2016, filed 13 May 2016.